Michael Dabrowski

Michael Dabrowski, PhD, is co-founder and CEO of Pelago Bioscience. A highly experienced in vitro pharmacologist and expert in biological assay development, Michael brings over 15 years of drug discovery expertise from leading pharmaceutical companies including Novo Nordisk and AstraZeneca. His career spans roles as senior scientist, technology specialist, project leader, and scientific manager. Michael has contributed across multiple therapeutic areas, consistently delivering strong results in science, project execution, team leadership, and budget management